NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Ajooni Biotech Received Repeat Export Orders From Bangladesh-Based Avon Animal Health

Updated on: 4 Nov 2024, 6:55 pm IST
Ajooni Biotech secures a repeat export order from Avon Animal Health, reporting Rs.82.30 crore revenue in FY24, with shares trading at Rs.7.13.
Ajooni Biotech Received Repeat Export Orders From Bangladesh-Based Avon Animal Health
Share

Ajooni Biotech Limited, known for its pure veg animal healthcare solutions, is celebrating a big win! The company has just bagged a repeat export order from Avon Animal Health, one of the biggest distributors of animal health products in Bangladesh. This will directly help deepen its footprint in the Asian market.

Products in Focus

The order includes key cattle feed supplements—Calcium, Mineral Mixture, Molasweet, and Rumesin. These products are designed to improve cattle health and productivity, aligning with Avon Animal Health’s overall vision, which is good livestock care in Bangladesh. Avon is known for its focus on distributing high-quality animal health products to commercial farms and breeding companies, making this a well thought of play for Ajooni Biotech.

Financials & Market Strategy

For Ajooni Biotech, this order isn’t just a win in terms of global presence, it’s a financial booster too. The company wrapped up FY24 with revenue of Rs.82.30 crore, an EBITDA of Rs.4.43 crore, and a net profit of Rs.2.17 crore. With this repeat export order, those numbers are only expected to climb as Ajooni pushes further into international markets.

Innovation & Quality at the Core

Ajooni Biotech has carved a niche for itself by offering PURE VEG animal feed products, a unique value proposition in the livestock care industry. The company’s focus on quality, safety, and innovation has helped it build trust with its clients. Jasjot Singh, Ajooni’s MD & CFO, commented, “This repeat order is a testament to the trust clients have in our products and shows our potential for market expansion.”

Ajooni Biotech’s stock is trading at Rs.7.13 today, showing a 3.78% drop. The stock has risen 22.51% year-to-date and 92.70% over the past year.

Conclusion Ajooni’s collaboration with Avon Animal Health is signalling that the company is on the right track in terms of its product range. With good financials and partnerships, Ajooni seems primed for growth and innovation in the global animal health industry.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.

Published on: Oct 25, 2024, 1:12 PM IST

Enjoy Zero Brokerage on Equity Delivery
10 Cr+DOWNLOADS

Enjoy ₹0 Account Opening Charges

Get the link to download the App

Scan this QR code to download the app
Get it on Google PlayDownload on the App Store

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91